This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Inflammatory Markers in Preeclampsia

This study has been completed.
Information provided by:
Oslo University Hospital Identifier:
First received: June 29, 2011
Last updated: July 15, 2011
Last verified: May 2011
This is an investigation of inflammatory markers in women destined to develop preeclampsia.


Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective

Resource links provided by NLM:

Further study details as provided by Oslo University Hospital:

Enrollment: 129
Study Start Date: January 1999
Study Completion Date: May 2004
Primary Completion Date: May 2004 (Final data collection date for primary outcome measure)
Pregnant women who develop preeclampsia
pregnant women who develop preeclampsia (n =43) compared to pregnant women fulfilling a normotensive pregnancy (n= 86).


Ages Eligible for Study:   20 Years to 43 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

The study comprised 43 pregnant women who developed preeclampsia and 86 pregnant women who fulfilled a normotensive pregnancy.

All women were of Caucasian origin, and were nulliparous.


Inclusion Criteria:

  • Caucasian origin

Exclusion Criteria:

  • Previous diseases e.g. cardiovascular disease, diabetes, hypertension, inflammatory bowel disease, serious organ disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

Responsible Party: Professor Lars Mørkrid, University of Oslo Identifier: NCT01385813     History of Changes
Other Study ID Numbers: INFLAMMARPE11
Study First Received: June 29, 2011
Last Updated: July 15, 2011

Keywords provided by Oslo University Hospital:
inflammatory markers
serological biobank
To assess whether the inflammatory markers could be useful
in order to identify pregnant women at risk to
develop preeclampsia

Additional relevant MeSH terms:
Hypertension, Pregnancy-Induced
Pregnancy Complications processed this record on September 21, 2017